Skip to main content
Log in

Systemic Adverse Effect of Antithyroid Drugs

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract:

Antithyroid drugs adverse effects are varied and rare. Autoimmune disorders (vasculitis, lupus erythematosus, polyarthritis . . .) are unusual and serious complications of antithyroid drugs. Since 1945, fewer than 100 cases of systemic manifestations related to antithyroid drugs have been reported in the literature, most frequently with propylthiouracil. The outcome is usually good after drug discontinuation, but some fatal cases have been reported. Because possible cross-sensitivity with other antithyroid drugs, the appropriate treatment for hyperthyroidism relapse if a patient has had an antithyroid drug adverse reaction, should be 131I-Iodine or surgery. We report four new cases of systemic manifestations during propylthiouracil therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 27 August 1996 / Accepted: 23 July 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mathieu, E., Fain, O., Sitbon, M. et al. Systemic Adverse Effect of Antithyroid Drugs. Clin Rheumatol 18, 66–68 (1999). https://doi.org/10.1007/s100670050057

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s100670050057

Navigation